Cervelo Pharmaceuticals was a private development company located in Mississauga, Canada. The company focused on in-licensing and developing mid-stage neurology small molecule drug candidates. The company aimed to advance therapeutics for neurological conditions, including pain management.
Neurological disorders
CTI LSF I
Lead
n/a
October 24, 2007
Liquidated in 2013
Convertible Note
Cervelo Pharmaceuticals could reach a value inflection quickly by acquiring promising drug candidates and efficiently advancing them through clinical development
